US 12,263,188 B2
Methods and compositions for treating stroke
Supurna Ghosh, Tacoma, WA (US); and Helmut Andreas Kalmes, Tacoma, WA (US)
Assigned to Revalesio Corporation, Tacoma, WA (US)
Filed by Revalesio Corporation, Tacoma, WA (US)
Filed on Feb. 26, 2021, as Appl. No. 17/187,437.
Application 17/187,437 is a continuation of application No. PCT/US2019/049196, filed on Aug. 30, 2019.
Claims priority of provisional application 62/726,166, filed on Aug. 31, 2018.
Prior Publication US 2021/0177891 A1, Jun. 17, 2021
Int. Cl. A61K 33/00 (2006.01); A61K 9/00 (2006.01); A61K 47/02 (2006.01); A61P 9/10 (2006.01)
CPC A61K 33/00 (2013.01) [A61K 9/0019 (2013.01); A61K 47/02 (2013.01); A61P 9/10 (2018.01)] 17 Claims
OG exemplary drawing
 
1. A method of treating, inhibiting, or ameliorating ischemic stroke or a symptom thereof in a subject, the method comprising:
identifying the subject as suffering from, or likely to be suffering from an ischemic stroke or a symptom thereof, and
administering an oxygenated fluid comprising charge stabilized oxygen-containing nanostructures to the subject intravenously at a rate of about 1 to 2 cc/kg/hr for a duration of at least 10 hours.